This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreau, M.-F.
Right arrow Articles by Langsley, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreau, M.-F.
Right arrow Articles by Langsley, G.

 Previous Article  |  Next Article 

Infection and Immunity, December 1999, p. 6678-6682, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Theileria annulata in CD5+ Macrophages and B1 B Cells

Marie-Françoise Moreau,1 Jean-Laurent Thibaud,1 Leila Ben Miled,1,2 Marie Chaussepied,1 Martin Baumgartner,1 William C. Davis,3 Paola Minoprio,1 and Gordon Langsley1,*

URA CNRS 1960, Department of Immunology, Pasteur Institute, 75724 Paris Cedex 15, France1; Laboratory of Veterinary Science, Institut Pasteur BP 74 Tunis, Tunisia2; and Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington3

Received 16 March 1999/Returned for modification 16 April 1999/Accepted 19 August 1999

Theileria parasites infect and transform bovine leukocytes. We have analyzed laboratory-established Theileria sp.-infected leukocyte lines and observed that transformed macrophages express CD5. Low-level expression of CD5 by macrophages was further confirmed on three independent Theileria annulata clinical isolates from Tunisia. Interestingly, the fourth CD5+ clinical isolate (MB2) was morphologically different, expressed surface immunoglobulin M (IgM) and BoLA class II, and had rearranged Ig light-chain genes. To demonstrate that MB2 did indeed contain CD5+ B cells, individual clonal lines were obtained by limiting dilution, and CD5 expression and Ig gene rearrangement were confirmed. This suggests that in natural infections T. annulata can invade and transform CD5+ B cells.


* Corresponding author. Mailing address: URA CNRS 1960, Department of Immunology, Pasteur Institute, 25, Rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33-1) 45688922. Fax: (33-1) 40613185. E-mail: langsley{at}pasteur.fr.


Infection and Immunity, December 1999, p. 6678-6682, Vol. 67, No. 12
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lizundia, R., Werling, D., Langsley, G., Ralph, S. A. (2009). Theileria Apicoplast as a Target for Chemotherapy. Antimicrob. Agents Chemother. 53: 1213-1217 [Abstract] [Full Text]  
  • Vera, J., Fenutria, R., Canadas, O., Figueras, M., Mota, R., Sarrias, M.-R., Williams, D. L., Casals, C., Yelamos, J., Lozano, F. (2009). From the Cover: The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc. Natl. Acad. Sci. USA 106: 1506-1511 [Abstract] [Full Text]  
  • Lizundia, R., Chaussepied, M., Huerre, M., Werling, D., Di Santo, J. P., Langsley, G. (2006). c-Jun NH2-Terminal Kinase/c-Jun Signaling Promotes Survival and Metastasis of B Lymphocytes Transformed by Theileria.. Cancer Res. 66: 6105-6110 [Abstract] [Full Text]  
  • Baumgartner, M., Angelisova, P., Setterblad, N., Mooney, N., Werling, D., Horejsi, V., Langsley, G. (2003). Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. Blood 101: 1874-1881 [Abstract] [Full Text]